Trial intelligence / Profile preview

Bococizumab in hypercholesterolemia on statin therapy

NCT01592240Phase 2Completed

Sponsor
Pfizer
Start
Jul 2012
Primary completion
Apr 2013
Countries
1
01

Overview

A Phase 2 trial of bococizumab in hypercholesterolemia, sponsored by Pfizer. Started Jul 2012; status: completed.

02

Drugs

bococizumab
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT01592240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01592240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call